Cycle Pharmaceuticals and Inceptua Group expand the Free Goods Programme for patients with Hereditar...

January 9, 2026

Cycle Pharmaceuticals Ltd (Cycle) and Inceptua Group (Inceptua) have announced the expansion of their partnership to make NITYR® (nitisinone) tablets ...

Groundbreaking myalgic encephalomyelitis study identifies over 250 core genes, shared biology with l...

December 4, 2025

The study reinforces that ME is a complex multisystemic condition with a clear genetic basis and lays the foundation for future clinical trials that c...

Lonza to expand bioscience testing offering with the acquisition of Redberry

October 30, 2025

Lonza to acquire Redberry SAS, an innovative company specializing in rapid microbiology testing solutions Acquisition to include Red One™ solid-phase ...

Newsroom

Categories

Choose a Category

Subscribe to Email Updates

EpiCypher launches Fiber-seq, a breakthrough multiomic single-molecule genomics assay

READ MORE

Aptamer Group introduces novel biomarker discovery service

READ MORE

Friends of Cancer Research and MMS collaborate to develop decision frameworks for interim overall survival data in oncology trials

READ MORE

Takara Bio Europe signs distribution agreement with MACHEREY-NAGEL to expand access to high-quality bioanalysis products

READ MORE

Alithea Genomics announces the launch of MERCURIUS™ FLASH-seq: a plate-based, full-length single cell RNA-seq kit delivering exceptional sensitivity and simplicity

READ MORE

Alithea Genomics launches MERCURIUS™ Total DRUG-seq: a next-generation full-length transcriptome profiling platform for high-throughput compound screening and target validation

READ MORE

Duke Street Bio receives FDA Fast Track designation for PARP1-Selective Inhibitor DSB2455 in patients with HRD brain metastases from triple-negative breast cancer

READ MORE

Ceryx Medical secures $15 million to advance groundbreaking heart failure technology

READ MORE

GenNext Technologies and Thermo Fisher Scientific collaborate to simplify structural biology for faster biotherapeutic development

READ MORE

Browse more news

Recent releases

Cycle Pharmaceuticals and Inceptua Group expand the Free Goods Programme for patients with Hereditar...

READ MORE

Groundbreaking myalgic encephalomyelitis study identifies over 250 core genes, shared biology with l...

READ MORE

Lonza to expand bioscience testing offering with the acquisition of Redberry

READ MORE

Useful information